About the Company
Tonix Pharmaceuticals (Tonix Pharmaceuticals Holding Corp.) is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TNXP News
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
CHATHAM, N.J., April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with ...
Tonix Pharmaceuticals Holding (TNXP) Price Target Decreased by 37.78% to 3.57
The average one-year price target for Tonix Pharmaceuticals Holding (NasdaqCM:TNXP) has been revised to 3.57 / share. This is ...
Tonix Pharmaceuticals Holding Corp (TNXP) Shares Plummet Below 1-Year High
Based on Tonix Pharmaceuticals Holding Corp (TNXP), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -11.04. The debt to ...
Immuron gains after Travelan sales update
According to the company, Travelan, an over-the-counter immune supplement indicated for travelers’ diarrhea, generated AUD$1.3M globally during the March 2024 quarter, with 51% YoY and 75% growth from ...
Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals among healthcare movers
Adial Pharmaceuticals (ADIL) +12%. Envoy Medical (COCH) +11%. Cartesian Therapeutics (RNAC) +11%. Losers: Marinus Pharmaceuticals (MRNS) -76%. Viracta Therapeutics (VIRX) -25%. ProMIS Neurosciences ...
Loading the latest forecasts...